Exane Derivatives’s Match Group MTCH Stock Holding History
Bought
Maintained
Sold
Other funds holding MTCH
Exane Derivatives's MTCH Position: Q2 2022 in Review
Exane Derivatives reduced its Match Group (MTCH) stake by 58% in Q2 2022, selling an estimated $83.8K and leaving 755 shares worth $52.6K. The position accounts for 0.03% of the portfolio, ranked #312.
Exane Derivatives first reported a position in MTCH in Q4 2020 and has held it in 7 quarters since. The position peaked at $355K in Q2 2021. 710 funds tracked by Wall St. Rank hold MTCH as of Q2 2022.
- Exane Derivatives held 755 shares of Match Group worth $52.6K as of Q2 2022.
- Exane Derivatives sold 1,034 Match Group shares in Q2 2022, an estimated $83.8K.
- Match Group made up 0.03% of Exane Derivatives's portfolio in Q2 2022, its #312 holding.
- Exane Derivatives first reported a position in Match Group in Q4 2020 and has held it in 7 quarters since.
- Exane Derivatives's Match Group position peaked at $355K in Q2 2021.
- 710 funds tracked by Wall St. Rank held Match Group as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.